Ilios Therapeutics

📍 Cambridge, United States👥 10 employees💰 Last funded May 2023
Biotechnology🌐 iliostx.com
Website LinkedIn
Ilios Tx is a pre-clinical platform therapeutics company that brings to life innovative multi-target molecules to counter neurodegenerative diseases. We are incubated at the Pagliuca Harvard Life Lab.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Italy
3
Germany
1
Frequently asked questions
Who invested in Ilios Therapeutics?
Ilios Therapeutics has 4 investors on record on gritt.io.
When did Ilios Therapeutics last raise funding?
The most recent investment in Ilios Therapeutics recorded on gritt.io was in May 2023.
What industry is Ilios Therapeutics in?
Ilios Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Ilios Therapeutics based?
Ilios Therapeutics is headquartered in Cambridge, United States.